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Background: Posttraumatic stress disorder (PTSD) is one of the most commonly observed stress-related conditions
following combat exposure and its effective prevention is a high health-care priority. Reports of peritraumatic
reactions have been shown to be highly associated with PTSD among combat exposed service members. However,
existing instruments measuring peritraumatic symptoms were not specifically developed to assess combat-related
peritraumatic stress and each demonstrates a different peritraumatic focus. We therefore developed the
Peritraumatic Behavior Questionnaire (PBQ), a new military-specific rating scale focused upon the wide range of
symptoms suggestive of combat-related peritraumatic distress in actively deployed Service Members. This study
describes the development of the PBQ and reports on the psychometric properties of its self-rated version (PBQ-SR).
Methods: 688 Marine infantry service members were retrospectively assessed by the PBQ-SR within the scope of
the Marine Resiliency Study after their deployment to war zone. Participants have been additionally assessed by a
variety of questionnaires, as well as clinical interviews both pre and post-deployment.
Results: The PBQ-SR demonstrated satisfactory internal consistency, convergent and discriminant validity, as well as
high correlation with trait dissociation prior to deployment. Component analysis suggested a latent bi-dimensional
structure separating a peritraumatic emotional distress and physical awareness factor. The PBQ-SR total score
showed high correlation to general anxiety, depression, poorer general health and posttraumatic symptoms after
deployment and remained a significant predictor of PTSD severity, after controlling for those measures. The
suggested screening cut-off score of 12 points demonstrated satisfactory predictive power.
Conclusions: This study confirms the ability of the PBQ-SR to unify the underlying peritraumatic symptom
dimensions and reliably assess combat-related peritraumatic reaction as a general construct. The PBQ-SR
demonstrated promise as a potential standard screening measure in military clinical practice, while It’s predictive
power should be established in prospective studies.
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Posttraumatic stress disorder (PTSD) is one of the most
common stress-related conditions in active duty Service
Members after combat exposure [1-3]. Early at-risk
detection and prevention of the development of PTSD
could therefore lead to substantial benefits concerning
the potential personal, social, and economic conse-
quences of this disorder in military populations [4-6].
Although prior literature has identified pre-existing and
post-hoc risk factors for PTSD, limitations in the pre-
dictive value of these factors have recently prompted
particular interest in the immediate peritraumatic re-
sponse after trauma exposure as a fairly robust predictor
of PTSD development.
Peritraumatic stress reactions refer to the different
stress-associated behavioral, emotional, cognitive, and
physiological symptoms during and immediately follow-
ing a traumatic event (e.g., fear of dying, fear of losing
emotional control, tachycardia, sweating, shaking, dizzi-
ness, dissociative symptoms, reduction of awareness,
etc.). These reactions have demonstrated a strong and
consistent association with the subsequent development
of posttraumatic stress symptoms [7-18]. The degree of
the peritraumatic adrenergic hyperactivation following a
stressful or traumatic event is related to different patterns
of physiological response [19], subjective experience of
injury and trauma-related fears [11,20], resilience and cop-
ing mechanisms [21], poor military training outcomes
[22,23], as well as symptomatic outcomes in trauma
sequelae [21,24]. Pathophysiological pathways suggested
for increasing the risk for PTSD include enhanced fear
conditioning [25], behavioral avoidance coping [26], mem-
ory processing disruption [27-30], and over-consolidation
of traumatic memories [31,32]. A prolonged continuation
of the biological and behavioral responses following acute
traumatic stress may lead to greater pairing of the trau-
matic memory with distress, initiating a cascade of sec-
ondary biological alterations with long-term adverse
consequences including interference with fear extinction
learning and retention [33-36]. Peritraumatic stress is, thus,
a salient pre-clinical indicator of risk and could provide
sufficient evidence to warrant evaluation, the provision
of stress first aid, and, if necessary, sustained formal
mental health intervention to promote healing and re-
covery [37-42].
Yet, the valid assessment of relevant behavioral, emo-
tional, cognitive, and physiological information is the
greatest challenge in combat-related, mental health
research. Although instruments measuring peritraumatic
symptoms exist, they were not specifically developed to
assess combat-related peritraumatic reactions. In addition,
the two most widely used peritraumatic scales each dem-
onstrate different peritraumatic foci. The Peritraumatic
Dissociative Experiences Questionnaire (PDEQ) mainlyassesses dissociative symptoms and physical reactions,
while the Peritraumatic Distress Inventory (PDI) primarily
targets emotional/cognitive peritraumatic aspects [43-47].
Thus, when used independently, these scales may insuffi-
ciently capture the wide range of possible symptoms or
reactions in the immediate aftermath of a combat-related
trauma.
To redress this problem, we developed the Peritrau-
matic Behavior Questionnaire (PBQ). The goal was to
generate a new, military-specific rating scale able to
unify the underlying peritraumatic symptom dimensions
and reliably assess combat-related peritraumatic reaction
as a general construct in actively deployed Service Mem-
bers. The goal of this primary study lies in the demon-
stration of satisfactory psychometric properties of the
subjective PBQ version (PBQ - Self Report, PBQ-SR).
Methods
Subjects
All subjects enrolled were consenting active duty male
Marines recruited from infantry battalions of the 1st
Marine Division stationed at Marine Corps Air-Ground
Combat Center, 29 Palms, or Camp Pendleton, in south-
ern California. Because the MRS study targeted only
ground combat units, no women were included in the
study. Ethnic distribution was included in similar pro-
portion to the representation in the Marine Corps [48]
(cf. Table 1, legend). There were no other exclusion cri-
teria. 706 deploying male Marines signed informed con-
sent prior to deployment and were included in the
study. Of all deployed participants, 688 Marines (mean
age 22.1 ± 3.4 years) participated in post-deployment
assessments, returned valid questionnaires and were
included in our analysis (cf. Table 1). Of those, 404
Marine subjects reported no history of prior combat
deployments.
Development of the peritraumatic behavior questionnaire
The goal was to develop a questionnaire that is easy to
administer and score due to its simple rating and scoring
instructions and clearly specified areas of evaluation. To
develop the content for the Peritraumatic Behavior
Questionnaire (PBQ) for use in a war zone, a panel of
subject matter experts generated an initial pool of items
and helped select the final set of items, emphasizing
content validity [49,50]. The expert panel was formed by
established clinical mental health professionals, with ex-
perience treating in-theater and post-deployment, com-
bat-related, acute and posttraumatic stress symptoms, as
well as research professionals with a focus in PTSD. The
PBQ-SR was developed using the expert consensus
method in four steps (Step 1: Item pool generation; Step
2: Item pool screening; Step 3: Items’ adjustment; Step 4:
Final review) [51].
Table 1 Means of psychometric scores assessed by different instruments in the sample




No prior deploymentb and PBQ > 12
(n = 70)
Mean SD Mean SD Mean SD
BAI - Post-deployment 4.2 7.0 4.1 7.0 9.9 11.1
BDI - Post-deployment 4.7 6.8 4.6 7.0 11.4 11.3
CAPS - Baseline 7.3 12.7 7.2 12.7 13.8 18.0
CAPS - Post-deployment 10.6 16.0 9.7 15.4 22.7 25.4
CAPS - Change 3.1 16.9 2.5 17.2 8.7 26.5
DES - Baseline 9.2 10.8 10.0 11.6 16.2 15.7
PCL - Baseline 22.7 8.7 22.9 8.9 27.5 10.5
PCL - Post-deployment 23.0 9.1 22.5 8.4 30.5 13.9
PCL - Change .3 9.8 -.4 9.7 3.0 13.6
PDEQ - Post-deployment 16.0 7.2 15.9 7.1 21.4 9.6
PBQ - Total Score 5.1 7.1 5.5 7.3 19.0 6.1
SF12 Physical Score - Post-deployment 53.6 6.54 54.0 6.3 52.6 8.4
SF12 Mental Score - Post-deployment 51.2 8.7 51.1 8.7 45.6 11.2
PANAS-Positive Post-deployment 33.9 9.0 34.1 9.1 34.5 9.4
PANAS-Negative Post-deployment 17.5 6.5 17.6 6.7 22. 5 7.4
WHODAS Post-deployment 13.9 4.2 13.9 4.4 17.0 7.2
Total scores of psychometric scores are reported as mean values ± SD. Measures were assessed either before (Baseline) or after deployment (Post-deployment).
Changes indicate differences in the scores between pre and post-deployment. BAI: Beck’s Anxiety Index; BDI: Beck’s Depression Inventory-II; CAPS: Clinician
Administered PTSD Scale; DES: Dissociative Experiences Scale-II; PANAS: Positive Affect Negative Affect Schedule; PDEQ: Peritraumatic Dissociative Experiences
Questionnaire - Self Report; PCL: PTSD Checklist; SF-12: Short Form 12, Version 2; WHODAS: World Health Organization Disability Assessment Schedule II.
a Demographics of whole sample in percentage (percentages under 1.0% are not reported).: Education (Some High School: 1.9%; GED: 1.5%; High School Diploma:
60.2%; Some College: 30.6%; Associates Degree: 2.5%; 4-year College Degree: 3.1%), Ethnicity (Not Hispanic or Latino: 74.6%; Mexican: 14.2%; Puerto Rican: 2.8%;
South or Central American: 3.2%; Other Spanish culture or origin: 5.2%), Race (Black or African American: 4.9%; American Indian or Alaskan Native: 1.5%; Asian:
2.7%; Native Hawaiian or Pacific Islander: 1.0%; White: 83.7%; More than one: 7.2%).
b There were no statistical significant differences in demographics between the different groups (data not shown).
† Drop-out reasons included transfer, hospitalization, relocation or discharge of Service Members.
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assessing peritraumatic reactions was generated. Con-
structs considered for inclusion were frequently observed
peritraumatic symptoms seen in the battlefield of opera-
tions. Items were collected through summarizing clinical
expertise derived from prior battle-field experience with
traumatized Service Members, clinical notes and prior
patients’ comments, a comprehensive literature review fo-
cused upon peritraumatic symptoms using a standard
database search, and well established peritraumatic and
dissociation questionnaires found to correlate with PTSD
development, trauma history or symptom severity (e.g.
Peritraumatic Distress Inventory – PDI; Peritraumatic
Dissociative Experiences Questionnaire – PDEQ; Somato-
form Dissociation Questionnaire - SDQ-20, Clinician
Administered Dissociative Symptoms Scale - CADSS)
[44,45,47,52-55]. In step 2, the item pool was screened to
determine: (a) the questions’ applicability and relevance to
military war zone experiences and culture and (b) the
feasibility of objectively observing described symptoms, an
attribute additionally rated by a focus group of Navy
corpsmen previously deployed with Marine combat units.
Peritraumatic reactions in battle are representative forextraordinary stress challenges for Service Members, who
are faced with pervasive loss, life threat, extreme physical
discomfort and moral conflicts, witnessing death and
overcoming fear [56]. However during combat, the pri-
mary importance of these reactions lies in potential inter-
ference with maintenance of operational resilience,
including mission effectiveness and optimal performance
[57]. Thus as those aspects of peritraumatic reactions are
already to deployed Service Members and salient to com-
bat operations, special attention has been given to includ-
ing such items in our questionnaire. Missing pool items
addressing possible emotional changes or loss of control
sometimes experienced in the aftermath of trauma or loss
were identified and consequently also included into the
item pool (i.e. items such as “acting inappropriately giddy
or silly”; “uncontrollable laughing, crying, or screaming”;
and “not feeling normally remorseful”). On the contrary,
several questions reflecting ubiquitous experiences in the-
ater (e.g., "I was afraid for my safety") were excluded from
the item pool. Step 3 included slight language modifica-
tions of the collected questions in order to reflect military
terminology and to qualify for use in military operational
settings. In the final step, the selected items were reviewed
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different battle-field related stress symptoms were ad-
equately represented in the draft.
A total of 15 potential scale items were then selected
from the remaining item pool (cf. Additional file 1). The
final questionnaire items were refined and assembled
into a 5-point-Likert scale structure, ranging from “Not
at All True” to “Extremely True” (scored 0–4), to pro-
mote the comparability of our results to prior studies
using existing questionnaires. Finally, the self-report ver-
sion (PBQ-SR) was created by merely using first-person
pronouns such as "I" and "my". All questions refer to
symptoms during and/or immediately after the most
stressful event experienced during the last deployment.
It was further specified in the measure’s instructions that
these reactions must have been unusual for the individ-
ual and not within their typical range of thoughts, emo-
tions or behavior. The PBQ-SR can be completed within
5 min. The 15 individual items were summed to com-
pute a single summary score. Higher scores indicate
higher levels of peritraumatic symptoms.
Methods
This study used data collected within the scope of the
“Validation of the Peritraumatic Behavior Questionnaire”
study, approved by the institutional review boards of the
University of California San Diego, the VA San Diego
Research Service (VA R&D and UCSD IRB approval
#090563), the Brooke Army Medical Center and CENT-
COM. This is a pilot study linked to the “Marine Resili-
ency Study” (MRS), a larger prospective investigation of
active duty Marines approved by the institutional review
boards of the University of California San Diego, VA San
Diego Research Service, and Naval Health Research
Center (VA R&D and UCSD IRB approval #070533) [48].
Informed consent for all deploying MRS Marines
volunteering for this study was obtained prior to deploy-
ment. The PBQ-SR was administered to Marines at
post-deployment assessment, along with other MRS
study questionnaires, as part of the standard test battery
for the MRS study. Exact post-deployment evaluation
time periods varied between 8 and 12 weeks post-
deployment depending on pre-scheduled assessment
time points. Each platoon of each company were avail-
able for ½ day for collection of data, including paper-
pencil questionnaires (approx. 1 ½ hrs). Two to four
study staff members were specifically designated for
monitoring of participants during questionnaires, as well
as being present to answer questions, but were not con-
stantly in the room where single participants filled out
self-report measures. Survey response confidentiality
was maintained at any time by providing spacing of at
least 5 feet between chairs/desks where self-report ques-
tionnaires were completed by participants. Assessmentswere mainly conducted in Marine training spaces on a
Marine Corps base, except for Marines not available to
be tested with their units if discharged after deployment,
transferred to a different unit or hospitalized. Those
Marines were assessed at the VA San Diego Medical
Center or at other locations.
Measures
All MRS participants completed the following question-
naire prior to deployment only:
– The Dissociative Experiences Scale-II (DES): The
DES is a 28-item, 11-point-Likert-scaled, self-report
questionnaire assessing dissociative symptomatology
during the past month. The DES has reported
satisfactory psychometric properties, while higher
scores indicate higher dissociative traits [58,59].
Participants also completed the following instruments
both pre- and post-deployment:
– The PTSD Checklist (PCL): The PCL, a 17-item,
5-point-Likert-scaled, self-report questionnaire
assessing PTSD symptom severity. The PCL has
repeatedly demonstrated good psychometric qualities
with higher scores indicating higher PTSD symptom
severity [60,61]. In our study the PCL was used with
respect to a specific traumatic event.
– The Clinician Administered PTSD Scale (CAPS): The
CAPS was administered by trained clinicians in a
face-to-face interview with MRS participants both
pre- and post-deployment. The CAPS is a structured
diagnostic interview that assesses the core and
associated symptoms of PTSD and is considered the
gold standard diagnostic manual for assessing PTSD
in clinical research [62-64]. While several scoring
rules and cut-off scores have been suggested, higher
scores indicate higher symptom severity [64].
Finally, in addition to the PBQ-SR, the following ques-
tionnaires were administered after deployment only:
– Peritraumatic Dissociative Experiences Questionnaire –
Self Report (PDEQ): The PDEQ is a 10-item,
5-point-Likert-scaled, self-report questionnaire
assessing peritraumatic dissociation. The PDEQ has
well-established psychometric properties, with higher
total scores indicating increased peritraumatic
dissociation [43,54] thus served as the reference
standard in the evaluation of the PBQ-SR.
– Positive Affect Negative Affect Schedule (PANAS):
The PANAS consists of two 10-item self-report scales
designed to provide independent measures of positive
(PANAS-P) and negative affectivity (PANAS-N).
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low scores reflect the absence of the reported feelings
[65,66].
– Beck Depression Inventory-II (BDI): The BDI is a 21-
item, four-point-Likert-scaled, self-rating scale
designed to measure emotional, cognitive,
behavioural and somatic symptoms of depression
over the previous two weeks and has become one of
the most widely accepted instruments for detecting
depression in normal populations [67,68].
– Beck Anxiety Index (BAI): The BAI is an established
21-item, four-point-Likert-scaled, self-report
instrument assessing severity of anxiety symptoms
during the past week [69].
– Short Form 12, Version 2 (SF-12): The SF-12 is a
widely used and repeatedly validated, 12-item, 5 and
3-point-Likert-scaled, self-report questionnaire
assessing health-related quality of life. Sub-scores are
divided according to physical and mental health
items. The SF-12 was developed as a more concise
alternative to the original SF-36 and has been shown
to mirror closely the physical and mental
components of the original form, such as pain,
general health, physical functioning, social
functioning, vitality, etc. [70].
–World Health Organization Disability Assessment
Schedule-II (WHODAS), Short Version: Developed
from the original 36-item version, the WHODAS-II,
Short Version is a 17-item, self-report generic health-
status instrument assessing functioning in the last 30
days in six domains: communication, mobility, self-
care, interpersonal, life activities, and participation
[71]. The first 12 items are 5-point Likert-scale
questions that assess areas of functioning while 5
additional items pertain to overall health, frequency of
functional impairments, and interference caused by
impairments. Only the 12 core items are aggregated
into a total score.
Statistical analysis
The main objective was the assessment of the major psy-
chometric properties of the PBQ-SR. Internal consistency
was assessed using corrected item-total correlations and
Cronbach’s alpha coefficients. Construct validity was
investigated by assessing the convergent and discriminant
validity of the measure with respect to previously estab-
lished measures. PBQ-SR internal consistency, as well as
convergent and discriminant reliability were explored
using the entire sample (N = 688). Concurrent validity of
the PBQ-SR was assessed in order to explore its correl-
ation to related measure scores assessed in our samples
after deployment. In order to avoid bias of combat-related
stresses or traumas associated with prior deployments, we
excluded previously deployed Marines from this analysis.Concurrent validity correlations and cut-off scores were
explored and calculated only in the sub-sample without
any history of prior deployment (N = 404). A CAPS
screening cut-off score of ≥45 was used to dichotomize
the population, as suggested in the literature [64]. Changes
in measures were computed as differences in total scores
between pre- and post-deployment. Preliminary analyses
were performed to ensure no violation of normality, lin-
earity and homoscedasticity. Descriptive statistics are
given in mean and standard deviation (SD) for ordinal
scaled variables. Correlations are reported by the Pearson
product–moment correlation coefficient and group differ-
ences were calculated by an independent-samples t-test.
All tests of significance were 2-tailed, and p-values < .05
were considered significant. Statistical analyses were con-
ducted using the Statistical Package for Social Sciences
Version 20 (SPSS Inc., Chicago, IL).
Results
Clinical characteristics
The means and SD of all instruments assessed are pre-
sented in Table 1.
Factor analysis
The 15 items of the PBQ-SR were subjected to principal
components analysis (PCA) with direct oblimin rotation
to investigate the underlying structure of the question-
naire. Prior to performing PCA, the suitability of data
was confirmed (Kaiser-Meyer-Olkin value: .893; Barlett’s
test of sphericity: p < .001). PCA suggested a two-factor
solution with only two components exceeding an eigen-
value >1, explaining 38.1% and 12.4% of the variance re-
spectively. An inspection of the screeplot revealed a
clear break after the second component. The two-factor
solution explained a total of 50.5% of the variance. The
correlation between the two factors was r = .39. Aligned
with the two-factor solution, we divided the two sub-
scales of the PBQ-SR, entitled Emotional Distress Sub-
scale (EDS) and Physical Awareness Subscale (PAS),
according to the different item content of the components
included. The EDS included emotional, perspective and
coping items, while the PAS reflected awareness, dissocia-
tive and physical symptom items.
Reliability
The PBQ-SR total score demonstrated good internal
consistency, with a reported Cronbach’s alpha coefficient
of .86. The inter-item correlation matrix revealed only
positive values (mean .331), indicating proper scoring
and that all items measured the same underlying attri-
bute. The corrected item-total correlations varied be-
tween .406 and .644 for all items, while deletion of
single items did not significantly change the alpha value,
suggesting that the sum of the 15 items is acceptable to
Table 2 Principal component analysis and convergent, discriminate and concurrent validity of the PBQ-SR
Item Item-total
correlation
α if Item deleted Mean SD Pattern coefficients Structure coefficients Communalities PDEQ PANAS-P CAPS†
Component Component
1 2 1 2
PBQ 1 .610 .851 .57 .953 .259 .550 .473 .650 .480 .347** -.038 .415**
PBQ 2 .406 .866 .71 1.120 -.214 .749 .078 .666 .482 .144** .052 .217**
PBQ 3 .516 .856 .30 .775 .021 .669 .281 .677 .459 .194** -.005 .197**
PBQ 4 .586 .853 .58 1.085 -.095 .832 .228 .795 .640 .232** .032 .286**
PBQ 5 .553 .857 .74 1.214 .061 .667 .321 .691 .481 .230** .007 .287**
PBQ 6 .481 .858 .21 .631 .132 .529 .338 .581 .352 .215** .027 .264**
PBQ 7 .546 .857 .15 .526 .410 .363 .551 .522 .415 .262** -.009 .230**
PBQ 8 .628 .853 .21 .593 .582 .294 .696 .520 .558 .286** -.046 .269**
PBQ 9 .644 .852 .21 .647 .703 .196 .779 .470 .640 .274** .014 .251**
PBQ 10 .424 .861 .10 .466 .785 -.143 .729 .162 .549 .192** .015 .120*
PBQ 11 .445 .861 .13 .477 .785 -.113 .741 .192 .560 .323** .034 .201**
PBQ 12 .534 .857 .19 .589 .581 .184 .653 .410 .455 .309** .028 .228**
PBQ 13 .453 .860 .15 .582 .813 -.124 .765 .192 .598 .280** -.062 .249**
PBQ 14 .548 .855 .45 .948 .208 .520 .410 .600 .397 .258** -.003 .275**
PBQ 15 .591 .852 .39 .889 .591 .228 .680 .458 .507 .399** -.002 .364**
PBQ Total 5.10 7.08 .422** .008 .436**
EDS .391** -.012 .309**
PAS .325** .017 .397**
Pattern and structure matrix of PCA with Oblimin rotation of two factor solution of PBQ-SR items and convergent, discriminate and concurrent validity of all items and total scores in the whole sample (n = 687).
Correlations are given by the Pearson’s r. PBQ: Peritraumatic Behavior Questionnaire; EDS: Emotional Distress Subscale; PAS: Physical Awareness Subscale; CAPS: Clinician Administered PTSD Scale; DES: Dissociative
Experiences Scale-II; PANAS-P: Positive Affect Negative Affect Schedule – Positive Affect Scale; PDEQ: Peritraumatic Dissociative Experiences Questionnaire – Self Report;.
# Statistical trend: .05 < p < 0.1.
* p < .05.
** p < .001.


















Table 3 Correlations of peritraumatic instruments to
measures assessed post-deployment in participants
without prior deployment (n = 404)
Scales PDEQ PBQ-SR EDS PAS
BAI .348** .478** .442** .385**
BDI .381** .531** .402** .487**
DES .220** .256** .188** .238**
CAPS .457** .400** .305** .361**
CAPS - Change .185** .201** .200** .148*
PCL .485** .488** .395** .423**
PCL - Change .103* .209** .227** .137*
SF-12 Physical -.037 -.086# -.143* -.031
SF-12 mental -.308** -.336** -.328** -.261**
WHODAS .266** .372** .384** .276**
PANAS - Negative .278** .384** .286** .358**
PANAS - Positive -.052 -.011 -.010 -.020
Correlations are given by the Pearson’s r. PBQ: Peritraumatic Behavior
Questionnaire; EDS: Emotional Distress Subscale; PAS: Physical Awareness
Subscale. BAI: Beck’s Anxiety Index; BDI: Beck’s Depression Inventory-II; CAPS:
Clinician Administered PTSD Scale; DES: Dissociative Experiences Scale-II;
PANAS: Positive Affect Negative Affect Schedule; PDEQ: Peritraumatic
Dissociative Experiences Questionnaire – Self Report; PCL: PTSD Checklist; SF-
12: Short Form 12, Version 2; WHODAS: World Health Organization Disability
Assessment Schedule II. Change indicates differences in the scores between
pre and post-deployment.
# Statistical trend: .05 < p < 0.1.
* p < .05.
** p < .001.
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battle-related trauma (cf. Table 2). The psychometric
properties of both subscales were computed separately.
The EDS and the PAS both displayed a good internal
consistency (Cronbach’s alpha = 0.80 and .85 respectively).
Construct validity
Convergent validity was assessed using a Pearson prod-
uct–moment correlation test to the PDEQ total score.
We observed a robust statistically significant positive
correlation between the total scores of the two measures
(r = .422, p < .001, n = 667), as well as between each of
the PBQ-SR items and PDEQ total score (cf. Table 2).
Discriminant validity was examined by exploring the
association between PBQ-SR total score and the diver-
gent and theoretically unrelated constructs of PANAS-P
scale. The PBQ-SR did not correlate with PANAS-P total
score at all (r = .008, p = .846, n = 661). In the sample
without prior deployment, PBQ-SR even showed a slight
negative discriminant correlation to the PANAS-P,
similarly to the PDEQ, confirming that the two scales
are both equally unrelated to a conceptually different
measure such the PANAS-P Scale. The EDS and the
PAS both also displayed a satisfactory convergent and
discriminant validity (cf. Table 2).
Concurrent validity
Concurrent validity was measured by exploring the rela-
tion of the PBQ-SR total score to several scales assessing
general anxiety, depression, negative affect, lower general
health and posttraumatic symptoms after deployment and
their changes over time, showing significant correlations
(cf. Table 3). In addition, the PBQ-SR showed a significant
positive correlation to the DES total score (r = .256;
p < .001, n = 401; cf. Table 3). The same correlations of
these measures to PDEQ were also computed and pre-
sented in Table 3. Controlling for CAPS and PCL baseline
scores had no significant effect on our results. The EDS
and the PAS both displayed a significant concurrent valid-
ity correlations to other measures (cf. Table 3).
Multivariate analyses
Hierarchical multiple regression models were used to
evaluate associations between PBQ-SR and PTSD symp-
tomology while controlling for co-morbid anxiety and
depressive symptoms, general health status, personality
and emotional trait factors in terms of criterion validity.
PTSD symptoms were indexed by CAPS and PCL total
scores, however due to their high collinearity, CAPS and
PCL total scores were entered as dependent variables in
separate regression models. Preliminary analyses were
conducted to ensure no violation of normality, linearity,
multicollinearity and homoscedasticity. BDI, BAI, WHO-
DAS, DES and PANAS-N total scores were entered asindependent variables at step 1 and PBQ-SR in step 2.
The final models were statistically significant and
explained a total variance of 34.7% (F(6, 389) = 34.4, p < .001)
and 47% (F(6, 389) = 57.6, p < .001) for CAPS and PCL
scores, respectively. After controlling for the other mea-
sures, PBQ-SR remained a significant predictor of PTSD
symptom severity as assessed by both measures (CAPS:
β= .232; 95%-CI: .025 – .439; t = 2.2; p = .028; PCL: β= .181;
95%-CI: .079 – .283; t = 3.5; p = .001).
Cut-off score
The relation between PTSD-risk status (CAPS score ≥ 45;
whole sample: 4.8%, no prior deployment: 4%) and the
PBQ total score was also examined using receiver oper-
ating characteristic (ROC) curves. Marines with a prior
deployment were excluded from the analysis. The area
under the curve was .85, which indicates that the PBQ
is quite accurate in identifying PTSD-risk positive
cases. The ROC diagram suggested a cut-off of 12
points (sensitivity 75.0%, specificity 85.6%) as the most
appropriate one for screening purposes. In a direct uni-
variate logistic regression, participants with a PBQ-SR
total score above 12 had a 17.9 odds ratio of PTSD-risk
group affiliation (B = 2.88; SE = .59; Wald = 23.5; df =1;
Sig. <.001; Exp(B) = 17.9). Also after controlling for
BDI, BAI, WHODAS and PANAS-N scores in a
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score above 12 was the only significant predictor of af-
filiation in the PTSD-risk group (full model: χ2 = 46.2,
p < .001, variance explained: 11.0 - 38.3%, PBQ-SR ≥12:
B = 1.76; SE = .73; Wald = 5.9; df =1; p = .015; Exp(B) =
5.8), indicating that the cut-off score selected was able
to distinguish between respondents. Using the PBQ-SR
cut-off score of 12 points as a dichotomous variable, we
compared the two resulting groups with respect to the
other psychometric measures. Participants reporting
PBQ-SR scores higher than the cut-off showed signifi-
cantly higher anxiety (BAI: t(399) = −5.075, p < .001),
depression (BDI: t(399) = −5.840, p < .001) and negative
affect (PANAS-N: t(399) = −6.117, p < .001) scores, lower
general health scores (WHODAS: t(399) = −4.171, p < .001)
and a greater increase of PTSD symptoms after deploy-
ment (CAPS-Change: t(395) = −2.232, p = .029; PCL-
Change: t(393) = −2.381, p = .020) than the control group.
Discussion
This study validates a new instrument for the assessment
of peritraumatic symptoms. To our knowledge, PBQ-SR
is the first instrument specifically designed to measure
several components of combat-related peritraumatic
stress. The questionnaire was assessed using retrospect-
ive data on 688 Marine infantry service members with
respect to the most stressful event during their last de-
ployment. PBQ-SR demonstrated satisfactory psycho-
metric properties with good internal consistency and
discriminant validity as to PANAS-Positive Score. De-
scriptive analysis of each item, inter-item correlation and
Cronbach's α stability after item deletion indicate that all
15 items of the questionnaire could be retained. The sta-
tistically significant positive correlation between both
the PBQ-SR total score and all of its 15 items to the
PDEQ confirms the ability of PBQ-SR to reliably assess
peritraumatic reactions as a general construct.
Consistent with prior results research [46], there was a
significant positive correlation between the PBQ-SR total
score and measures of general anxiety, depression, nega-
tive affect and lower general health after deployment.
PBQ-SR also showed high concurrent validity with re-
spect to posttraumatic symptoms after deployment and
their changes over time. PTSD severity strongly corre-
lated not only with PBQ-SR total scores and the two
subscales, but also with most of the fifteen individual
PBQ-SR items. In order to compare the concurrent psy-
chometric properties of PBQ-SR to PDEQ, we recalcu-
lated all correlations with respect to PDEQ (cf. Table 3).
Our results suggest similar psychometric properties,
while the PBQ-SR shows slightly better concurrent valid-
ity to almost every other measure assessed (cf. Table 3).
Linear and logistic regressions have shown that PBQ-
SR total score remained a significant predictive factor ofPTSD symptom severity, even after controlling for de-
pression, general anxiety, negative affect and general
health. Our results suggest a PBQ-SR cut-off score of 12
points for screening purposes. This score has been
shown to correctly classify respondents at risk for PTSD
even after controlling for other psychopathologies. In
addition, participants exceeding this cut-off score also
showed significantly higher anxiety, depression and
negative affect scores, lower general health scores and a
greater increase of PTSD symptoms after deployment
when compared to the control group.
As literature suggests that peritraumatic symptoms
partly rely on pre-existing factors, such as trait dissoci-
ation and may be an important risk factor for PTSD de-
velopment and resilience [24,72,73], we also investigated
the correlation between peritraumatic symptoms (PBQ-
SR), trait dissociation assessed by the DES and posttrau-
matic symptoms (CAPS). Our results showed a statisti-
cally significant correlation between all three scores and
confirm prior findings. However, even though the DES
total score also correlated significantly with the CAPS
total score (r = .188, n = 394, p < .001), the close correl-
ation of PBQ-SR to the CAPS total score remained
significant even after controlling for trait dissociation
(r = .370, n = 393, p < .001).
A principal component analysis suggested the existence
of two underlying factors: physical/dissociative (PAS) and
perceptive/emotional (EDS) aspects of peritraumatic stress
reaction. Both factors have demonstrated satisfactory con-
vergent validity to PTSD specific measures and significant
concurrent validity correlations to other measures such as
general anxiety, depression, negative affect and general
health (cf. Tables 2 and 3). At present, the two pre-existing
scales assessing peritraumatic reactions (PDEQ and PDI)
seem to each focus separately on different dimensions of
peritraumatic symptoms. PDEQ’s underlying structure is
shown to reflect more dissociative symptoms such as
altered awareness and derealization (reflecting the PAS),
while PDI focuses more on emotional peritraumatic distress
symptoms (reflecting the EDS). Hence, our results suggest
that PBQ-SR is a new scale that may have incremental val-
idity by unifying and assessing the two major underlying
peritraumatic symptom dimensions, which would other-
wise require the administration of both PDEQ and the PDI.
Assessing both dimensions also affirms the clinical rele-
vancy of PBQ-SR and we therefore support the use of both
subscales in clinical practice. The separate use of EDS and
PAS could, however, be considered in psychiatric research.
In summary, our study replicates and extends the find-
ings of other studies reporting peritraumatic dissociation
to be a robust correlate of PTSD symptoms in adults.
Our findings suggest that peritraumatic symptoms as
measured by the PBQ may be useful indices of risk and
need for early intervention for PTSD in service members
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ively validated through immediate peritraumatic assess-
ment through in-theater administration of the PBQ-SR
in the future.
Limitations and strengths
Because the content development focused on the behav-
ioral indicators of the phenomenology of service members
under great strain in a war-zone, the PBQ stands out as a
peritraumatic index uniquely suitable for military mem-
bers. The PBQ is a questionnaire that is easy to administer
and score due to its simple rating and scoring instructions
and clearly specified areas of evaluation. The 5-point-
Likert scale structure promotes the comparability of our
results to prior studies using already existing scales. Con-
cerning the psychometric properties of the PBQ-SR,
excluding Marines with prior deployments from the pre-
dictive analyses has contributed to the reduction of bias
risk due to prior stressors, while the use of the trauma-
specific CAPS score likely contributed to a higher specific
predictive power of our results. The size, as well as the
homogeneity of our assessed sample (Marine, infantry) in
terms of gender, age and kind of exposure type is a specific
feature and further strength of our study, compared to val-
idation studies designed for other scales. This may be an
advantage for military-use of the questionnaire, but may
limit its generalizability to other populations. In addition,
as the optimal cutoff score was empirically established in
our study, cross-validation in an independent sample
appears necessary. Further limitations also include the
lack of assessment of prior traumatic life events or child-
hood trauma, combat exposure level and test-retest vari-
ability of the measure. In addition, we evaluated the PBQ-
SR on male Marine Corps infantry units who deployed to
Afghanistan in a period of time that was relatively quies-
cent. It is an empirical question whether these results
would be generalizable to more highly exposed troops, in
other branches of service, and with women. However, the
most significant limitation of the study is the retrospect-
ive, self-report assessment of peritraumatic symptoms,
which precludes a conclusion on predictive validity of the
PBQ-SR. Retrospective assessment of symptoms may also
lead to distortion of recollections or bias due to current
symptoms [74] and subjective assessment of combat-
related symptoms could introduce bias and distortions
related to cognitive barriers (i.e. fear of stigma, warrior
ethos, criticism, fear of removal from unit, etc.) and adap-
tive denial coping mechanisms of Service Members [2,75].
Despite those concerns, our results suggest good reliabil-
ity, validity and applicability of the PBQ-SR.
Conclusion
The PBQ-SR is a reliable and valid new instrument for
globally assessing different underlying dimensions ofcombat-related peritraumatic symptoms in active duty
Service Members and demonstrates high correlation to
various PTSD-specific, as well as related symptoms. The
PBQ-SR may contribute to more accurate and earlier
identification of individuals at high risk for developing
combat-related acute and posttraumatic stress symp-
toms, allowing for further monitoring, coping support or
immediate evidence-based treatment. The ability of the
PBQ-SR to serve as a standard self-rated questionnaire
with incremental validity in military clinical practice and
predictive validity towards PTSD development, should,
however, be prospectively validated through immediate,
in-theater peritraumatic assessment in future studies.
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